Cancer Immunotherapy Market Size Is Likely To Reach USD 126.9 Billion By 2026 : Grand View Research Inc.

 lily mathew
  22nd-Jul-2019
 51

San Francisco, 22 July 2019: The Report Cancer Immunotherapy Market Analysis Report By Product (Oncolytic Viral Therapies & Cancer Vaccines, Monoclonal Antibodies, Immunomodulators), By Cancer Type (Breast, Lung), and Segment Forecasts, 2019 – 2026

The global cancer immunotherapy market size is likely to reach USD 126.9 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 9.6% during the forecast period. Increasing patient pool and higher mortality rate are augmenting the need for cancer immunotherapy globally. Furthermore, increasing number of approvals for new immunotherapeutic drugs is driving the global market.

Cancer immunotherapy has emerged as a new avenue for revenue generation for pharmaceutical companies. In addition, adverse effects, such as recurrence of cancer and organ failure, associated with conventional chemotherapies and rising demand for technologically advanced healthcare solutions are boosting the demand for immunotherapies. Moreover, introduction of newer drug classes, such as target receptors for multiple myeloma and checkpoint inhibitors, is poised to make way for advanced therapeutics in the market.

Introduction of new molecules has been proving to be beneficial for patients who are not responding to chemotherapy. Several new immunotherapeutic options, such as immunomodulators and CAR-T cell therapy, are in the pipeline and are being tested for their ability to provide better cancer treatment.

Monoclonal antibodies are the most widely used immunotherapeutic drugs globally. Development of monoclonal antibodies as effective immunotherapeutic options started after the approval of Blincyto (blinatumomab) by Amgen, a bispecific antibody that targets B-cell lymphoblastic leukemia. Increasing R&D pertaining to the use of monoclonal bodies as naked antigen binding antibodies, conjugated, and bispecific antibodies is resulting in discovery of new therapeutic options for cancer treatment.

Access Research Report of Cancer Immunotherapy Market @ www.grandviewresearch.com/industry-analysis/cancer-immunotherapy-market

Further key findings from the report suggest:

  • Majority of immunotherapy drugs are being used in treatment of cancer of lung, breast, and prostate
  • Monoclonal antibodies emerged as the largest segment because of increasing regulatory approvals and higher efficacy
  • Lung cancer accounted for the largest share in 2018 and will continue to dominate the market through 2025
  • North America was the leading revenue contributor in the market in 2018. Rising incidence of cancer and increasing demand for novel technologies are facilitating the dominance of the region during the forecast period
  • Europe is projected to witness rapid growth during the forecast period owing to rapid adoption of advanced cancer therapeutics for effective treatment
  • Some of the key players are Amgen, Inc.; AstraZeneca; F. Hoffmann La Roche Ltd.; Bayer AG; Bristol-Myers Squibb Company; Eli Lilly and Company; Merck and Co., Inc.; Novartis AG; and Pfizer, Inc.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the global cancer immunotherapy market based on product, cancer type, and region:

Cancer Immunotherapy Product Outlook (Revenue, USD Billion, 2015 - 2026)

  • Monoclonal Antibodies
  • Immunomodulators
  • Oncolytic Viral Therapies and Cancer Vaccines

Cancer Immunotherapy Cancer Type Outlook (Revenue, USD Billion, 2015 - 2026)

  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Melanoma
  • Prostate Cancer
  • Head and Neck Cancer
  • Ovarian Cancer
  • Pancreatic Cancer

Cancer Immunotherapy Regional Outlook (Revenue, USD Billion, 2015 - 2026)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Access Press Release of Cancer Immunotherapy Market @ www.grandviewresearch.com/press-release/global-cancer-immunotherapy-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Domain: Medical
Category: Therapy
Contact Person Address: vrushali@grandviewresearch.net
Posted By: lily mathew and Contact lily mathew

Recent Press Releases

Airport Security Market - Competitor...

Market Scenario:.The increasing need for stringent security to ensure passenger safety against terrorist activities is primarily driving the growth of this market. Similarly, strin

15 September, 2019

Will everyone get varicose veins?

Varicose veins are those swollen veins that bulge and visible above one’s outer surface of the skin. These may look blue or dark purple in colour in a bit twisted form. Varic

15 September, 2019

Dental Lab Market - Emerging Innovat...

The rapid growth in the geriatric population and the associated increase in the prevalence of edentulism, growing dental tourism in emerging markets, rising incidence of dental car

15 September, 2019